Evidence map›Paper›PMID 30159314›Full record

ReviewFrontiers in medicine2018

Understanding Urogenital Schistosomiasis-Related Bladder Cancer: An Update.

Kenji Ishida, Michael H Hsieh

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Review
  4. Review
  5. Review
  6. O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.International journal of molecular sciences · 2024
    Review
  7. Review
  8. Review
  9. Bladder cancer.Nature reviews. Disease primers · 2023
    Review
  10. Modelling morbidity for neglected tropical diseases: the long and winding road from cumulative exposure to long-term pathology.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  11. Review
  12. Article
  13. Review
  14. Urine microbiome in individuals with an impaired immune system.Frontiers in cellular and infection microbiology · 2023
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kenji IshidaBladder Immunology Group, Biomedical Research Institute, Rockville, MD, United States.
Michael H HsiehBladder Immunology Group, Biomedical Research Institute, Rockville, MD, United States.

Funding

Therapeutic Exploitation of IPSE, a Urogenital Parasite-Derived Host Modulatory Protein, for Bladder Hypersensitivity SyndromesR01DK113504 · NIDDK · CHILDREN'S RESEARCH INSTITUTE · PI HSIEH, MICHAEL HARRISON · 2017 to 2021
$2.4M
NIDDK NIH HHS R01 DK113504
6 · The paper itself

Abstract

Infection with

Indexed as

bladderbladder cancercancermouse modelsschistosomiasisschistosomiasis haematobia

Identifiers

PMID30159314
PMCPMC6104441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.